Correlation Engine 2.0
Clear Search sequence regions

  • antipsychotics (1)
  • china (1)
  • city (1)
  • delirium (1)
  • humans (1)
  • mania (1)
  • patients (5)
  • psychosis (3)
  • research (2)
  • sars cov (3)
  • south africa (4)
  • Sizes of these terms reflect their relevance to your search.

    SARS-CoV-2 was first identified in Wuhan City, China, in 2019. Initially it was associated with the development of pulmonary disease, but research over the past 2 years has identified effects on multiple systems. Neuropsychiatric manifestations of COVID-19 have been reported in countries around the world, including new-onset psychosis in patients with no personal or family psychiatric history. We present the first case series describing neuropsychiatric manifestations of patients in Johannesburg, South Africa (SA). All four patients presented with their index-episode psychosis, and evidence of COVID-19 infection. The patients had varied psychiatric presentations, from delirium and psychosis to mania, and all responded well to low doses of antipsychotics. One patient had newly diagnosed HIV in addition to COVID-19. Further research is needed to determine the prevalence of neuropsychiatric manifestations in acute SARS-CoV-2 infections in SA.


    S Fernandes, N Marques, L Goga. The complexity of neuropsychiatric manifestations of COVID-19 in South Africa. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 2022 Apr 29;112(5):313-316

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 35587242

    View Full Text